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Abstract
While recent findings have established that cells derived from the bone marrow can contribute to vasculogenesis in the adult, it is unclear
whether an analogous population of cells in the embryo can also contribute to vasculogenesis. Using a retroviral labeling strategy, we
demonstrate that circulating blood island-derived cells contribute to the genesis of both extra- and intraembryonic blood vessels in the early
quail embryo. This finding establishes that vasculogenesis in the embryo is a composite of two processes: the direct in situ formation of
blood vessels from mesodermally derived angioblasts and the incorporation and differentiation of circulating endothelial cell progenitors
into forming embryonic blood vessels.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Two distinct neovascular processes mediate new blood
vessel formation, vasculogenesis and angiogenesis. Angio-
genesis is the formation of blood vessels from endothelial
cells of preexisting vessels, while vasculogenesis is the de
novo formation of blood vessels from mesoderm. Vasculo-
genesis was once thought to be restricted to only the earliest
stages of development, with subsequent vascular growth
being mediated by angiogenesis. This view has changed
with the demonstration that the initial vascularization of
developing organs such as the kidney (Robert et al., 1998;
Tufro et al., 1999), lung (deMello et al., 1997; Gebb and
Shannon, 2000), and liver (Matsumoto et al., 2001) occurs
by vasculogenesis. In addition, vasculogenic blood vessel
formation is now known to occur in the adult. The study of
Asahara et al. (1997) was seminal in bringing the concept of
adult vasculogenesis to the forefront. This group demon-
strated that a population of circulating CD34 mononuclear
cells isolated from human peripheral blood were able to
participate in adult neovascularization in a mouse ischemia
model (Asahara et al., 1997). Studies evaluating the trans-
differentiation potential of transplanted bone marrow cells
further support the concept of adult vasculogenesis (Asa-
hara et al., 1999a; Ikpeazu et al., 2000; Shi et al., 1998,
1999). Together, these studies established that bone mar-
row-derived cells are a source of new endothelial cells that
participate in neovascular processes in the adult.
The finding that circulating endothelial progenitor cells
contribute to neovascularization in the adult led us to in-
vestigate whether a similar process is operative in the em-
bryo. Given the extensive vasculogenic activity associated
with embryogenesis and the fact that the vertebrate embryo
possesses structures analogous to the bone marrow, the
blood islands, it was postulated that blood island-derived
circulating cells participate in embryonic vasculogenesis.
Using a retroviral based lineage-tracing strategy, we dem-
onstrate that circulating blood island-derived cells contrib-
ute to new blood vessels in both extra- and intraembryonic
regions. These findings suggest that embryonic vasculogen-
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esis is a composite of both in situ vasculogenesis and vas-
culogenesis mediated by circulating cells.
Materials and methods
Animals
Fertile Japanese quail (Coturnix coturnix japonica) eggs
were obtained from Manchester Farms (Dalzel, SC). Fertile
specific pathogen-free (SPF) chicken (Gallus domesticus)
eggs were obtained from Hy-Vac (Adel, IA).
Tracing vectors
Replication-defective pseudotyped retrovirus that expresses
human histone H2B-yellow fluorescent fusion protein
(H2B-YFP) was obtained from Dr. Rusty Lansford (California
Institute of Technology, Pasadena, CA). The H2B-YFP retro-
viral vector was assembled with the G envelope protein of
vesicular stomatitis virus (VSV-G). Pseudotyping, or the
exchange of surface antigen among both DNA and RNA
virus, allows the host range of viruses to be altered to possess
a broad host range (Zavada, 1982). In addition, this allows the
virus to be concentrated 1000-fold with minimal loss of bio-
logical activity (Burns et al., 1993). In test experiments, the
VSV-G pseudotyped retrovirus efficiently (99%) infected
avian cells throughout embryonic development (data not
shown). The infected cells appear to follow their normal mi-
gratory routes and undergo normal differentiation. The retro-
virus used in these studies was constructed by fusing cDNA
encoding human histone H2B to the gene encoding the Yel-
low Fluorescent Protein (YFP) and cloning the fusion gene
into the pCLNCX vector (Kanda et al., 1998). H2B-YFP
expression was driven by the chick -actin promoter/CMV
enhancer transcription unit EF-1 promoter (Mizushima and
Nagata, 1990). The viral titer was between 5  108 and 1 
109 pfu/ml.
Fig. 1. YFP expression is observed in extra- and intraembryonic regions 15 h after injection of retroviral tracer into quail blood island primordia. Shown in
(A) is an LSCM image of a 13-somite stage quail embryo that was injected with retrovirus at the 2-somite stage and cultured for 15 h. Numerous YFP cells
are evident in areas where blood vessels are found within the extraembryonic (i.e., yolk sac) and intraembryonic (i.e., lateral networks) portions of the embryo
and absent in avascular regions, i.e., Henson’s node (star). (B) A higher magnification image of the boxed area in (A) showing the distribution of YFP cells
(green) within the QH1 immunolabeled (red) blood vessels of the sinus venosus. Scale bars: (A) 200 m; (B) 50 m.
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Embryo microinjection and culture
Detailed methods for preparing, microinjecting, and cul-
turing quail embryos have been described previously (Drake
et al., 1992a; Packard and Jacobson, 1979). Briefly, primi-
tive streak to two-somite-stage embryos were removed from
the yolk by using a paper ring and placed ventral side up on
an agar bed in Dulbecco’s phosphate-buffered saline
(DPBS; Gibco BRL/Life Technologies, Baltimore, MD).
Microinjection was accomplished by using a transmitted
light stereomicroscope, a micromanipulator, and an injec-
tion pump. Nanoliter-sized aliquots of reagent (approxi-
mately 1 ng/nl in 10 or 20 nl) were delivered into the
extracellular matrix separating the splanchnic mesoderm
and the endoderm. After microinjection, embryos were
washed three times in DPBS. For heart extirpation, the
bilateral heart fields were excised at the six-somite stage by
using a fine carbon steel blade (Electron Microscopy Sci-
ences, Fort Washington, PA). All embryos were cultured
(0.5–22 h) in DMEM (Gibco) containing 10% chicken se-
rum (Gibco) and 1% penicillin streptomycin/L-glutamine
(Gibco) in a humidified CO2/air mixture (5%/100%) at
37°C.
Embryo fixation and immunolabeling
Embryos were rinsed in DPBS and fixed in 3% parafor-
maldehyde for 45 min. After washing in PBS containing
0.01% azide, the vitelline membrane was removed. Em-
bryos were permeabilized in absolute methanol at 20°C
for 1 h, rehydrated through a graded series of ethanol/water
solutions, and then blocked overnight at 4°C using 3%
BSA/PBS. The embryos were washed and immunolabeled
overnight at 4°C using QH1 hybridoma supernatant, a quail-
specific endothelial cell marker (QH1 hybridoma superna-
tant developed by F. Dieterlen was obtained from the De-
velopmental Studies Hybridoma Bank developed under the
auspices of the NICHD and maintained by The University
of Iowa, Department of Biological Sciences, Iowa City, IA)
and/or rabbit anti-recombinant TAL1 IgG (obtained from
Dr. Steven Brandt, Vanderbilt University, diluted to 1 g/
ml). After washing, secondary fluorochrome-conjugated an-
tibodies (Jackson Immunological Research Labs Inc., West
Grove, PA) were added at 10 g/ml and incubated for 6 h.
The labeled embryos were mounted under a #1 coverslip
using anti-bleaching mounting medium [5% n-propyl gal-
late, 0.25% 1,4 diaza-bicyclo-(2,2,2) octane, and 0.0025%
phenylendiamine in glycerol (Giloh and Sedat, 1982)].
Laser scanning confocal (LSCM) and differential
interference contrast (DIC) microscopy
LSCM
Embryos were analyzed by using a BioRad MRC-1024
laser scanning confocal microscope and Adobe PhotoShop
7.0 image processing software. Using previously described
procedures, the embryos were scanned in a plane parallel to
Fig. 2. Retroviral injection of quail blood island primordia results in three
populations of YFP cells. When retrovirally injected embryos were im-
munolabeled with antibodies to QH1, a quail-specific endothelial cell
marker, at the 12-somite stage and imaged using LSCM, numerous YFP
(green) cells were associated with the QH1 (red) intraembryonic blood
vessels of the lateral networks. Arrows indicate YFP cells within the
lumen of the QH1 vessels. Arrowheads show elongated cells that appear
to be intercalated into the vascular endothelium. Asterisk indicates YFP
cells within the avascular mesoderm. Scale bar, 25 m.
Fig. 3. LSCM shows YFP cells incorporated into intraembryonic vessels.
Shown is a LSCM image from a retrovirally injected embryo immunolabeled
with antibodies to QH1 at the 12-somite stage. The image was generated by
optically sectioning the intraembryonic blood vessels from the lateral networks
along their longitudinal axis and then compositing 2 serial Z-sections (total
thickness of 4 m) acquired midway through the vessel. The level of the
sections chosen passes through the vascular endothelium and the lumen of the
vessel at its largest diameter. Arrowhead shows YFP cells incorporated into
the QH1 vascular endothelium. Avascular space and lumen of the blood
vessel are labeled. Scale bars, 25 m.
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the embryonic plate (Drake et al., 1997). Individual optical
planes were sequentially analyzed for TAL1 and QH-1
immunolabeled cells. The final images were projections of
20 optical planes collapsed using BioRad software to
produce a single virtual image representing the TAL1 or
QH-1 immunolabeling of all blood vessels in the optical
field.
DIC
Embryos were evaluated by using a Leica DMR light
microscope equipped with epifluorescence capabilities
(Vashaw Scientific, Inc., Norcross, GA). Images were pro-
cessed by using NIH Image 1.62 (National Institutes of
Health) and Adobe Photoshop 7.0 software (Adobe Sys-
tems, Inc., San Jose, CA).
Results
Blood island-derived YFP cells can be detected within
the embryo proper
To evaluate whether cells of blood island origin partic-
ipate in intraembryonic vasculogenesis, the extraembryonic
mesoderm that is the primordia of the blood islands (prim-
itive streak to 2-somite stage) was microinjected with 20 nl
of H2B-YFP-expressing retrovirus (n  30). Examination
of embryos 15 h postinjection (11–13 somite stage) using
laser scanning confocal microscopy (LSCM) revealed
YFP cells in both extra- and intraembryonic regions (Fig.
1A). To relate the distribution of YFP cells to the devel-
oping blood vessels, retrovirally labeled embryos were im-
munolabeled with antibodies to QH1, a carbohydrate that is
expressed on the surface of quail endothelial cells (Drake et
al., 1997; Pardanaud et al., 1987; Peault et al., 1983). Fig.
1B is a high magnification composite of a YFP image
(green) and the corresponding QH1 image (red) of blood
vessel in the area of the sinus venosus (boxed area in Fig.
1A).
YFP cells are present as endothelial cells, circulating
cells, and cells within the splanchnic mesoderm
Three populations of YFP cells were detected within
the embryo proper (intraembryonic regions) 15 h postinjec-
tion using LSCM. Each of these populations was evident in
areas lateral to the axis at the level of the 3rd through 8th
somites. The first population of YFP cells (Fig. 2, arrow-
heads) was closely associated with the vascular endothelium
(QH1 cells). A second population of YFP/QH1 cells
was evident within the lumen of the blood vessels (Fig. 2,
arrows). A third and less prominent population of YFP/
QH1 cells was found within the avascular splanchnic me-
soderm (Fig. 2, asterisks).
To evaluate whether the YFP cells associated with the
vascular endothelium were endothelial cells, the morphol-
ogy of the cells was examined by using LSCM and differ-
ential interference contrast microscopy (DIC). Fig. 3 shows
two YFP cells (arrowhead) within the QH1 vascular
epithelium. In contrast to the round nuclei of YFP cells
observed within the lumen of the vessel (Fig. 2), the nuclei
of YFP cells within the vascular endothelium had an
elongated shape. The YFP cells incorporated into the vas-
cular endothelium were also imaged by using epifluores-
cence and DIC microscopy (Fig. 4). A high magnification
image of a segment of a blood vessel from a retrovirally
injected embryo immunolabeled with QH1 (red) revealed
three YFP cells (green) that coexpress QH1 (Fig. 4A,
arrows). When the same field was examined by using DIC
microscopy, the nuclei of the three YFP cells (Fig. 4B,
arrows) were indistinguishable from those of adjacent en-
dothelial cells. Both the YFP/QH1 cells and the YFP/
QH1 cells exhibited nuclei that were elongated in shape.
Similarly, comparison of the morphology of endothelial
cells in control embryos (Fig. 4D, arrows) with the YFP
cells in endothelium of experimentally manipulated em-
bryos (Fig. 4C, arrows) revealed that, at least at the gross
level, the cells shared morphological characteristics.
YFP endothelial cells express the transcription factor
SCL/TAL1
SCL/TAL1 is a helix–loop–helix transcription factor that
is expressed in both angioblasts and newly differentiated
endothelial cells and is immunohistochemically localized to
the nucleus of both cell types (Drake et al., 1997; Drake and
Fleming, 2000; Kallianpur et al., 1994). To evaluate
whether the YFP cells also expressed TAL1, in addition to
possessing morphological characteristics of endothelial
cells, retrovirally injected embryos were immunolabeled
with antibodies to QH1 and TAL1. Fig. 5A is a LSCM
image of QH1-labeled blood vessels from the region of a
12-somite-stage embryo located lateral to the axis and be-
tween somites 3 and 8. Fig. 5B depicts TAL1 expression in
the same optical field. Elongated TAL1-positive nuclei are
evident at the margin of the vessel. When the pattern of
QH1, TAL1, and YFP expression was superimposed (Fig.
5D), a subpopulation of YFP cells was found that coex-
pressed both QH1 and TAL1 (arrowheads). The expression
of TAL1 in YFP endothelial cells is consistent with the
pattern of gene expression that defines vasculogenesis
(Drake et al., 1997, 2000; Drake and Fleming, 2000).
YFP endothelial cells within the embryo proper are
derived from circulating cells
The experiments above establish the presence of YFP
endothelial cells in the blood vessels of the embryo proper
(intraembryonic regions). While these experiments suggest
that these cells were derived from circulating cells of ex-
traembryonic origin, there are other possibilities that could
account for the presence of YFP endothelial cells within
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the intraembryonic vasculature. These possibilities include:
(1) YFP cell migration/viron diffusion, (2) viron diffusion
via circulation, and/or (3) viral recombination.
YFP cell migration and viron diffusion
To evaluate whether YFP cells at the site of injection
migrated into the embryo and/or whether free viron diffused
throughout the tissue and subsequently infected cells of the
embryo proper, the distance of YFP cells from the site of
injection was analyzed as a function of time. These exper-
iments are schematically outlined in Fig. 6. Extraembryonic
blood island primordia of primitive streak stage embryos
were retrovirally injected and the embryos cultured for
specific time periods (0.5, 1, 2, 4, 5, 6, and 10 h) to allow for
viron incorporation and cell migration and/or viron diffu-
sion. At the end of the culture period, the extraembryonic
tissue was separated from the intraembryonic tissue. The
two fragments (extra- and intraembryonic) were then cul-
tured separately for an additional 16–22 h to allow suffi-
cient time for viral protein expression. The time period was
determined based on an evaluation of the minimum time
required from viral infection to nuclear YFP fluorescent
protein expression, which was shown to be 6.5 h (data not
shown). Analysis of the cultured intraembryonic fragments
revealed a complete lack of YFP expression (Fig. 6A and
B). In contrast, YFP cells were evident in the correspond-
ing extraembryonic tissues (Fig. 6C and D). Microinjected,
uncut embryos that were cultured for 16–22 h had numer-
ous YFP cells in both the extra- and intraembryonic por-
tions (Fig. 6E and F). As no gradient of YFP cells was
observed from the site of injection toward the axis of the
embryo, the findings of this experiment suggest that the
YFP cells/endothelial cells are neither the result of YFP
cell migration nor viron diffusion, but rather are the result of
circulating YFP cells of extraembryonic origin. This is
also supported by the fact that YFP cells within the em-
bryo are not located in regions previously described as
avascular, i.e., those adjacent to Henson’s Node (Fig. 1A,
star).
Viron transport via the circulation
While the above findings establish that infected cells do
not simply migrate through the mesoderm or that virons
diffuse and infect intraembryonic endothelial cells, they do
not rule out the possibility that free virons gain access to
intraembryonic endothelial cells once the circulation is es-
tablished. To evaluate this possibility, the set of experiments
outlined in Fig. 7 was conducted. Our observations of car-
diovascular development reveal that extraembryonic de-
rived blood cells first gain access to the embryo proper
when heartbeat is initiated at the 10-somite stage. Based on
this fact and the fact that the minimal time from infection to
YFP expression was determined to be 6.5 h (data not
shown), primitive streak-stage embryos were infected, cul-
tured to the 12-somite stage, and examined by using LSCM.
The clear presence of YFP cells incorporated into blood
vessels of the embryo proper at 4.5 h after circulation is
initiated argues for an extraembryonic origin of YFP cells
(Fig. 7E, upper panel).
To confirm that circulation is required for transport of
YFP cells from the extraembryonic blood islands to the
embryo proper, the distribution of YFP cells was evalu-
ated in embryos in which the heart was extirpated. To
achieve this, the blood island primordia of primitive
streak-1 somite stage were retrovirally labeled and the em-
bryos cultured to the 6-somite stage. At this time, the bilat-
eral heart-forming fields were extirpated and the embryos
cultured for an additional 15 h. In embryos in which the
extirpation completely ablated cardiac development, (6 out
of 8 embryos), no YFP cells were detected within the
embryo proper. In contrast, YFP cells were detected in-
traembryonically in the remaining two embryos (embryos in
which cardiac function was only partially disrupted). These
findings suggest that the circulation acts as the conduit for
YFP cells from the extraembryonic blood islands to the
embryo proper.
Viral recombination
Despite the fact that the retrovirus used was designed to
be replication defective and tested for replication compe-
tency using cell lines, the possibility existed that in an in
vivo setting, a three-way recombination event could have
occurred. As the quail eggs routinely used in this study are
not tested for pathogens, the presence of a wildtype virus in
the egg could result in the generation of a replication com-
petent virus (Ory et al., 1996). To address this possibility,
primitive streak-staged embryos from specific pathogen-
free (SPF) chicken eggs were retrovirally injected in the
area of the blood islands and cultured 15 h as described
above. Examination of SPF chicken embryos shows that,
like retrovirally labeled quail embryos, blood island-derived
fluorescent cells were incorporated into the intraembryonic
blood vessels of the embryo proper (Fig. 8). While incor-
poration into the vasculature of quail embryos was demon-
strated by the colocalization of QH1 immunolabeled cells
and virally infected fluorescent cells (Fig. 8A, arrows),
incorporation of fluorescent cells into blood vessels of SPF
chicken embryos was evaluated by using a combination of
fluorescence and DIC imaging (Fig. 8B, arrows), as QH1
does not react in the chicken. The use of SPF embryos in
conjunction with retroviral vectors eliminated the possibil-
ity that replication competent virus was the source of la-
beled cells within the embryo proper.
Discussion
Our findings establish that the blood islands are a source
of circulating cells that contribute to the formation of new
blood vessels in both the extra- and intraembryonic regions
of the embryo. Using a retroviral labeling strategy in con-
junction with confocal, DIC and epifluorescence micros-
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copy, we have demonstrated that YFP cells of blood island
origin incorporate into the vascular endothelium of intraem-
bryonic blood vessels. The fact that the cells are integrated
into the endothelium of the blood vessels (Figs. 3 and 4) and
the fact that these cells coexpress the markers QH1 and
TAL1 (Fig. 5), which were previously described to be
expressed by avian endothelial cells (Drake et al., 1997,
2000), indicate that these YFP cells are endothelial cells.
The blood island-origin of the YFP cells detected
within the blood vessels of the embryo and the circulation as
a mechanism of their distribution is indicated by our find-
ings that alternative scenarios that could account for these
cells (i.e., cell migration/viron diffusion, viron diffusion via
circulation, and/or viral recombination) are not operative.
With regard to YFP cell migration and viron diffusion, we
detect no YFP cells either within the embryo proper or in
a gradient toward the embryo proper in experiments in
which extraembryonic and intraembryonic portions of the
embryos were separated at a specific time point post-injec-
tion (Fig. 6). In addition, as all injections were conducted at
the primitive streak–2-somite stage, a period in develop-
ment prior to generation of blood vessels, the possibility of
immediate viral transport via the circulation was negated.
The time at which the embryos were injected was insuffi-
cient to allow free virons to have entered the embryo proper
and for the cells within the embryo proper to express YFP
once the circulation is established (Fig. 7). Finally, to ensure
that the YFP cells detected were not the result of viral
recombination, we demonstrated a similar experimental out-
come using SPF chick embryos (Fig. 8). Our contention that
the YFP endothelial cells that we observed intraembryoni-
cally are derived from cells of blood island origin that gain
access to the embryo via the circulation is consistent with
the fact that such cells are absent in areas that had not been
Fig. 4. DIC demonstrates incorporation of YFP cells into the intraembryonic vasculature. (A) A high magnification fluorescent image of YFP cells (green,
arrows) within a segment of a QH1 intraembryonic blood vessel (red) from the lateral networks. (B) The same field taken using DIC to reveal the nuclear
shape of the constituent endothelial cells. (C) An overlay of the fluorescent and DIC images that shows the morphology of the YFP cells intercalated into
the endothelium. (D) A DIC image of a blood vessel segment from a noninjected stage-matched normal embryo. Comparison of YFP cells (C, arrows) and
normal endothelial cells (D, arrows) demonstrates that the YFP cells have a phenotype characteristic of normal endothelial cells intercalated into the vascular
endothelium. Avascular space, lumen of the blood vessel and red blood cells (RBCs) within the lumen are labeled. Scale bars: (A–D) 25 m.
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vascularized (i.e., areas adjacent to Henson’s node). Addi-
tionally, heart extirpation, in which cardiac function was
ablated, resulted in no intraembryonic YFP cells. To-
gether, the above findings suggest that the YFP endothelial
cells detected in intraembryonic regions are derived from
extraembryonic blood islands and that these cells entered
the embryo via the circulation and participated in the vas-
culogenic process. While the pattern of YFP endothelial
cells suggests that their incorporation into the vascular en-
dothelium may not be random, for example no YFP cells
were incorporated into the dorsal aortae, it is unclear if
circulating cells discriminate between arteries and veins.
While this is possible, the differences in the distribution
pattern may reflect the fact that our labeling strategy gen-
erates only finite numbers of labeled cells and that such cells
entering the circulation are initially exposed to venous ves-
Fig. 5. YFP endothelial cells express TAL1. LSCM images (4 m thickness) of an intraembryonic lateral vascular network from a 12-somite stage
retrovirally injected embryo showing QH1 immunolabeling (A), TAL1 immunolabeling (B) and immunofluorescence of retrovirally labeled cells (C). (D)
YFP endothelial cells (arrowheads) coexpress QH1 and TAL1, an expression pattern consistent with that previously described for endothelial cells. In
addition, YFP cells within the vascular lumen express TAL1 (arrow). Avascular space and lumen of the blood vessel are labeled. Scale bar, 50 m.
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sels (i.e., the sinus venosus). Alternatively, the difference in
the distribution of YFP cells may reflect whether the
vessel was established primarily by in situ vasculogenesis
(i.e., the dorsal aortae).
In addition to YFP endothelial cells, we observed other
populations of YFP cells (Fig. 2). Prominent among these
were YFP cells within the lumen of blood vessels. Given
that the retroviral labeling experiments targeted the blood
islands, some of these cells are likely of the hematopoietic
lineage (i.e., erythroid cells, myeloid cells). Others likely
represent circulating endothelial cells or endothelial cell
progenitors. This later conclusion is based on our finding the
YFP endothelial cells incorporated into intraembryonic
vessels and evidence that such cells gained access to the
embryo proper via the circulation. In addition to YFP cells
associated with blood vessels, YFP cells were also ob-
served within the connective tissue of the splanchnic meso-
derm. While the nature of these cells is unclear, there is
reason to believe that they may represent a population of
extravasated monocytes (macrophages) of blood island or-
igin, as several studies suggest that the early embryo con-
tains yolk sac-derived macrophage-like cells (Cuadros et al.,
1992; Martin-Partido et al., 1991).
While our finding that circulating cells contribute to the
neovascularization of the early embryo is in accord with
similar findings in the adult, it is at odds with other works
Fig. 6. YFP cells within the embryo do not result from cell migration or diffusion of unincorporated virons. This schematic shows the approach used to
evaluate cell migration and viron diffusion. Blood island primordia were retrovirally infected and the embryo cultured for 30 min to 10 h. For half of the
injected embryos (upper panels), the extraembryonic region was separated from the intraembryonic region and the two fragments cultured separately for an
additional 16–22 h. Control embryos were cultured intact for 16–22 h. (lower panels). No YFP cells were detected in the intraembryonic vasculature of
dissected embryos (A,B), while YFP cells were apparent in the extraembryonic fragments of dissected embryos (C, D) and the vasculature of intact embryos
(E, F). Note: The contrast levels were increased in (A) and (B) to reveal structures. Scale bars: (A, C, E) 200 m; (B, F) 100 m; (D) 50 m.
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that have examined this potential in the embryo. In a study
closely related to our own, Cuadros et al. (1992) reported
the presence of patches of QH1 endothelial cells in blood
vessel walls of chick embryos after quail yolk sac (contain-
ing blood islands) transplantation. While we consider this
observation as support for our findings, it must be noted that
the authors concluded that the yolk-sac/blood islands were
not a source of cells contributing to vasculogenesis based on
the failure of the reciprocal experiment to produce endothe-
lial cells of donor origin. Similarly, Kurz et al. (2001)
concluded that circulating cells did not contribute to in-
traembryonic vasculogenesis. This potential was investi-
gated in quail-chick chimeras by using peripheral blood
transplantation, bone marrow transplantation and parabiosis
experiments (quail and chick embryos cocultured such that
their chorioallantoic circulations become continuous). They
found that regardless of the source of cells introduced into
the extraembryonic circulation, no donor endothelial cells
were found as a part of the host embryonic blood vessels.
While it is difficult to explain the conflicting results between
Fig. 7. Free virons do not gain access to the embryo proper via circulation. This schematic depicts experiments addressing the ability of free virons to infect
resident intraembryonic endothelial cells via circulation. Retrovirus was injected into the blood island primordia at the primitive streak–2 somite stage and
embryos allowed to culture for 15 h. During this period, the extra- and intraembryonic vasculatures anastamose and circulation begins, allowing either virally
infected cells (upper panels) or free virons (lower panels) access to the embryo proper. Embryos were examined at 13 somites by using LSCM, and YFP
cells were observed within the embryo proper. Given that the minimum time between injection and viral expression was determined to be 6.5 h and the
initiation of cardiac function does not occur until the 10 somite stage, providing a maximum of 4.5 h between viron access via circulation and fixation of
the embryos, it was concluded that YFP cells were not derived from postanastamosis viral infection, but from an extraembryonic source. “s” indicates somite
number. Scale bars, 50 m.
Fig. 8. Viral recombination does not contribute to YFP expression in intraembryonic endothelial cells. Blood island primordia of both quail and SPF chick
embryos were retrovirally labeled at the primitive streak–2 somite stage and embryos were allowed to culture 15 h. Arrows in (A) show YFP cells (green)
incorporated into QH1 (red) quail intraembryonic blood vessels from the lateral networks. (B) (arrows) Similar results from a SPF chick embryo (YFP
cells are green, vessels are imaged by using DIC). Avascular space, lumen of the blood vessel and red blood cells (RBCs) within the lumen are labeled. Scale
bars, 25 m.
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the above studies and our own, possible explanations lie in
differences between the stages studied and the markers
used. Our studies were conducted at significantly earlier
stages and used retroviral markers to trace the fate of blood
island-derived cells rather than the expression of QH1. In
contrast to previous studies, the use of a retrovirus as a
lineage-tracing tool allows the cells to be followed in a
tissue independent process.
Given the evidence supporting a common origin for the
hematopoietic and endothelial cell lineages from a cell re-
ferred to as the hemangioblast, it is tempting to interpret our
findings as support for such a cell. However, our experi-
ments do not distinguish whether endothelial cells and he-
matopoietic cells have a common or separate cell origin.
While the specific origin of cells within the circulation that
have endothelial cell potential is unclear, there is convincing
evidence that populations of both circulating endothelial
cell precursors (Ikpeazu et al., 2000; Lin et al., 2000; Shi et
al., 1998, 1999; Takahashi et al., 1999) and so-called cir-
culating endothelial cells in the adult (Grefte et al., 1993;
Lin et al., 2000; Solovey et al., 1997) can contribute to
neovascularization.
The findings of our study are significant in two respects.
First, the fact that two mechanisms for vasculogenesis are
operative in embryos, in situ and circulating vasculogenesis,
necessitates a reappraisal of previous results that attribute
experimental outcomes solely to the process of vasculogen-
esis or angiogenesis. Second, considering the importance of
understanding regulation of new blood vessel formation as
it occurs in adult vasculogenesis, the development of model
systems to elucidate mechanisms controlling this process is
useful. The work presented herein suggests that the embryo
may be a valuable experimental model to address many of
the outstanding questions regarding the regulation of circu-
lating endothelial cell precursors and/or endothelial cells.
For example, what controls the numbers of extraembryonic
circulating cells that participate in vasculogenesis and what
mechanisms regulate their homing and incorporation into
the vascular endothelium? Does VEGF, a cytokine known
to be involved in both embryonic (Drake et al., 2000; Drake
and Little, 1995) and adult (Asahara et al., 1999b) vascu-
logenesis, play a role in this regulation? As the avian em-
bryo is easily manipulated, we feel that experiments ad-
dressing these and other questions are highly feasible and
should provide new insights into vasculogenesis occurring
via circulating cells.
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